Abstract
ObjectivesOptimal management of patients with stage IA p53abn endometrial cancer without myoinvasion, classified as intermediate risk in the 2020 European Society of Gynaecological Oncology, European Society for Radiotherapy and Oncology,...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have